Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin for Perimenopausal Symptoms
NCT06192641Phase 2Completed
- Sponsor
- Univates
- Start
- Oct 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melatonin in perimenopause, sponsored by Univates. Started Oct 2023; status: completed.
02
Drugs
melatonin
03
Conditions
perimenopause
Beyond the preview
Go deeper on NCT06192641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06192641.